Cargando…

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities

INTRODUCTION: Many patients are referred to multiple sclerosis (MS) tertiary centers to manage brain white matter hyperintensities (WMH). Multiple diagnoses can match in such situations, and we lack proper tools to diagnose complex cases. OBJECTIVE: This study aimed to prospectively analyze and corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levraut, Michael, Landes, Cassandre, Mondot, Lydiane, Cohen, Mikael, Bresch, Saskia, Brglez, Vesna, Seitz-Polski, Barbara, Lebrun-Frenay, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990749/ https://www.ncbi.nlm.nih.gov/pubmed/35401550 http://dx.doi.org/10.3389/fimmu.2022.864133

Ejemplares similares

Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
por: Levraut, Michael, et al.
Publicado: (2023)

Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review
por: Levraut, Michaël, et al.
Publicado: (2019)

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)

A Prospective Study of Patients with Brain MRI Showing Incidental T2 Hyperintensities Addressed as Multiple Sclerosis: a Lot of Work to do Before Treating
por: Lebrun, Christine, et al.
Publicado: (2014)

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
por: Lebrun, Christine, et al.
Publicado: (2018)

Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
por: Capet, Nicolas, et al.
Publicado: (2021)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis
por: Lebrun, Christine, et al.
Publicado: (2017)

Impact de la vaccination ou de l’infection COVID-19 sur une cohorte de sujets présentant un syndrome radiologique isolé : l’étude VaxiRIS
por: Thomel-Rocchi, Océane, et al.
Publicado: (2023)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
por: Allouche, Jonathan, et al.
Publicado: (2022)

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020)

Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study
por: Merindol, Julie, et al.
Publicado: (2023)

I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes
por: Bertelsen, Trine, et al.
Publicado: (2021)

Soluble interleukin-2 receptors in ulcerative colitis
por: Nielsen, O. H., et al.
Publicado: (1993)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis
por: Levraut, Michael, et al.
Publicado: (2021)

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
por: Levraut, Michael, et al.
Publicado: (2022)

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
por: Manni, Sabrina, et al.
Publicado: (2023)

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France
por: Graça, Daisy, et al.
Publicado: (2023)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation
por: Lokau, Juliane, et al.
Publicado: (2016)

Soluble Interleukin-6 Receptor Regulates Interleukin-6-Dependent Vascular Remodeling in Long-Distance Runners
por: Villar-Fincheira, Paulina, et al.
Publicado: (2021)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation
Publicado: (1986)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Letter to the editor on “new algorithmic approach for easier and faster extended disability status scale calculation”
por: Cohen, Mikael, et al.
Publicado: (2023)

Elevation of soluble interleukin-2 receptor levels in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Purification and characterization of a novel soluble receptor for interleukin 1
Publicado: (1991)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis
por: Otto, Carolin, et al.
Publicado: (2020)

Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
por: Diep, Sydney, et al.
Publicado: (2022)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
por: Stone, Katie, et al.
Publicado: (2013)

Crevicular fluid levels of interleukin-8, interleukin-17 and soluble intercellular adhesion molecule-1 after regenerative periodontal therapy
por: Erdemir, Ebru Olgun, et al.
Publicado: (2015)

A model of the ternary complex of interleukin-10 with its soluble receptors
por: Pletnev, Sergei, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_prkol7hmv05sepfnperbgoc9j8